GUANGXI XINYIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD – Trademark Portfolio
Entity Type: 99
GUANGXI XINYIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 21 (Housewares) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AOJOO. The owner is based in NANNING CITY.
ROOM 1202, UNIT 3, YONGKAI MODERN CITY,
NO. 82, DONGGE ROAD, QINGXIU DISTRICT
NANNING CITY 530000 , CN
Showing of trademarks Trademarks
Trademark Classifications
GUANGXI XINYIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does GUANGXI XINYIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD have?
GUANGXI XINYIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does GUANGXI XINYIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD file in?
GUANGXI XINYIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 21 (Housewares), Class 10 (Medical Apparatus). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.
What are GUANGXI XINYIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD's most well-known trademarks?
GUANGXI XINYIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD's registered trademark portfolio includes well-known marks such as AOJOO. These are among 2 currently registered trademarks in the portfolio.
What is GUANGXI XINYIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD's trademark registration success rate?
GUANGXI XINYIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.